林志郎
, M.D.
單位: 基隆長庚紀念醫院 
現職: 胃腸肝膽科主治醫師
聯絡地址: 基隆市安樂區麥金路222號
電話:02-24313131 傳真: 02-24335342
E-mail:
lion@cgmh.org.tw
研究領域:- 醫學之生化及分子生物
- Hepatology Virology
工作經歷:基隆長庚醫院主治醫師
學歷:高雄醫藥大學
代表論文:1. Chih-Lang Lin.; Chien, Rong-Nan; Hu, Ching-Chih; Lai, Ming-Wei; Yeh,
Chau-Ting*. Identification of hepatitis B virus rtS117F substitution as
acompensatory mutation for rtM204I during lamivudine therapy.
J Antimicrob Chemother. 2012 Jan;67(1):39-48.
2. Ching-Chih Hu, Chih-Lang Lin, Yen-Lin Kuo, Cheng-Hung Chien ,
Li-Wei Chen , Cho-Li Yen, Rong-Nan Chien. Efficacy and safety of
ribavirin plus pegylated interferon alfa in geriatric patients with chronic
hepatitis C Alimentary Pharmacology and Therapeutics 2013
Jan;37(1):81-90.
3. Lin CL, Chien RN, Lin SM, Ke PY, Lin CC, Yeh CT*. An occult hepatitis
B-derived hepatoma cell line carrying persistent nuclear viral DNA and
permissive for exogenous hepatitis B virus infection. PLoS One 2013
May29;8(5):e65456.
4. Chen CH & Lin CL(共同第一), Hu TH, Hung CH, Tseng PL, Wang JH, Chang JY, Lu SN, Chien RN*, Lee CM*. Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation. J Hepatol. 2014 Jun;60(6):1127-34.
5. Chih-Lang Lin,Rong Nan Chieh,Charisse Yeh,Chao-Wei Hsu,Ming-Ling Chang Yi-Cheng Chen, Chau-Ting Yeh.Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy:a case control study. Scandinavian Journal of Gastroenterology (In press)
